Enteroviral protease 2A cleaves dystrophin: Evidence of cytoskeletal disruption in an acquired cardiomyopathy

Citation
C. Badorff et al., Enteroviral protease 2A cleaves dystrophin: Evidence of cytoskeletal disruption in an acquired cardiomyopathy, NAT MED, 5(3), 1999, pp. 320-326
Citations number
45
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Medical Research General Topics
Journal title
NATURE MEDICINE
ISSN journal
10788956 → ACNP
Volume
5
Issue
3
Year of publication
1999
Pages
320 - 326
Database
ISI
SICI code
1078-8956(199903)5:3<320:EP2CDE>2.0.ZU;2-N
Abstract
Enteroviruses such as Coxsackievirus B3 can cause dilated cardiomyopathy, b ut the mechanism of this pathology is unknown. Mutations in cytoskeletal pr oteins such as dystrophin cause hereditary dilated cardiomyopathy, but it i s unclear if similar mechanisms underlie acquired forms of heart failure. W e demonstrate here that purified Coxsackievirus protease 2A cleaves dystrop hin in vitro as predicted by computer analysis. Dystrophin is also cleaved during Coxsackievirus infection of cultured myocytes and in infected mouse hearts, leading to impaired dystrophin function. In vivo, dystrophin and th e dystrophin-associated glycoproteins alpha-sarcoglycan and beta-dystroglyc an are morphologically disrupted in infected myocytes. We suggest a molecul ar mechanism through which enteroviral infection contributes to the pathoge nesis of acquired forms of dilated cardiomyopathy.